Eton Pharmaceuticals (ETON) Receivables (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Receivables of $11.8 million for Q4 2025, down 10.13% sequentially from $13.1 million in Q3 2025, and up 119.31% YoY from $5.4 million in Q4 2024.
Eton Pharmaceuticals (ETON) Receivables (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Receivables for 7 years, with the latest figure at $11.8 million in Q4 2025.
- Quarterly Receivables rose 119.31% year-over-year to $11.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.8 million (up 119.31% YoY) and the FY2025 annual result came in at $11.8 million, up 119.31% from the prior year.
- Receivables fell to $11.8 million in Q4 2025 per ETON's latest filing, from $13.1 million in the prior quarter.
- Over five years, Receivables peaked at $14.5 million in Q2 2025 and troughed at $300000.0 in Q1 2021.
- A 5-year average of $4.4 million and a median of $3.5 million in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2021 and 2022: Receivables jumped 10316.67% in 2021, then sank 62.96% in 2022.
- Over 5 years, Receivables stood at $5.0 million in 2021, then sank by 62.96% to $1.9 million in 2022, then jumped by 84.18% to $3.4 million in 2023, then soared by 57.17% to $5.4 million in 2024, then surged by 119.31% to $11.8 million in 2025.
- According to Business Quant data, Receivables over the past three periods registered $11.8 million, $13.1 million, and $14.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 24.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.89 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | 13.08 Mn |
| Jun 30, 2025 | 14.45 Mn |
| Mar 31, 2025 | 4.33 Mn |
| Dec 31, 2024 | 5.36 Mn |
| Sep 30, 2024 | 5.59 Mn |
| Jun 30, 2024 | 4.87 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 2.87 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 834,000.00 |
| Mar 31, 2022 | 796,000.00 |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 385,000.00 |
| Jun 30, 2021 | 303,000.00 |